# Article Title

Latest News from Pharma-Watch

FDA to convene Dec. 8 meeting on drospirenone risks

Drospirenone birth control (Yaz, others) to be topic of FDA special meeting Dec. 8 examining deep-vein thrombosis risks (Oct. 11, 2011) – The U.S. Food & Drug Administration plans to convene a joint

Australian health officials want doctors to tell diabetics of pioglitazone risks for bladder cancer

Australia to doctors: tell diabetics of ‘small absolute increased risk’ of bladder cancer from pioglitazone (Oct. 7, 2011) Australian health officials – concerned over published reports in British

Modafinil product information changed by Cephalon after closer look by Australian health officials

Cephalon changes product info after Australia takes closer look at modafinil (Oct. 7, 2011) Pharmaceutical maker Cephalon recently updated the safety literature it packages with modafinil following a

Metal hip implants may cause crippling injuries -- study

Crippling injuries from shavings cut loose by worn-out metal-on-metal artificial hips may be in store for tens of thousands of U.S. patients, if the results of a new British study are any indication.

FDA safety alert issued following Multaq clinical trial

Multaq study finds two-fold increase in deaths, strokes; FDA issues safety alert (July 21, 2011) The U.S. Food and Drug Administration issued a Drug Safety Communication about Multaq side effects, noting “a